<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>23545115</identifier>
<setSpec>1579-2021</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Pérez, Antonio</dc:author>
<dc:author>Sánchez-Quesada, José Luis</dc:author>
<dc:description xml:lang="en">Prevention of high incidence of cardiovascular disease in diabetes is one of the challenges of endocrinology. Validation of new biomarkers that may contribute to a better assessment of cardiovascular risk and help implement treatment strategies is one of the promising approaches in research on prevention and reduction of cardiovascular risk. Modification of low density lipoprotein (LDL) is a key element in development of atherosclerotic lesions. Several pathophysiological characteristics of diabetes are crucial for the LDL of these patients to have higher modification rates as compared to the healthy population. Diabetic dyslipidemia, hyperglycemia, and oxidative stress synergistically promote the occurrence of lipoperoxidation, glycosylation and glycoxidation processes, which will generate modified lipoproteins that stimulate development of atherosclerosis. This article reviews the role of different types of modified LDL in development of atherosclerosis in diabetes, as well as the possibility of using its quantification in cardiovascular risk prediction.</dc:description>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>Arteriosclerosis</dc:subject>
<dc:subject>Diabetes mellitus</dc:subject>
<dc:subject>Atherosclerosis</dc:subject>
<dc:subject>Cardiovascular risk</dc:subject>
<dc:subject>Riesgo cardiovascular</dc:subject>
<dc:subject>Biomarkers</dc:subject>
<dc:subject>Modified lipoproteins</dc:subject>
<dc:subject>Biomarcadores</dc:subject>
<dc:subject>Lipoproteínas modificadas</dc:subject>
<dc:date>2013 Nov </dc:date>
<dc:title xml:lang="en">Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus.</dc:title>
<dc:publisher>Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion</dc:publisher>
</metadata>
</record>
</pubmed-document>
